Zeba M Khan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Replacement Therapy

Heart Rate Variability

Glycemic Control

Top Venues

Expert review of pharmacoeconomics & outcomes research

Journal of market access & health policy

This page only lists publications with an associated author ORCID identifier.

Publications

Pierre Levy, Tobiasz Lemański, Catriona Crossan, Anna Lefebvre, Jean-Baptiste Brière, Luca Degli Esposti, Zeba M Khan
Cost-effectiveness analysis comparing single-pill combination of perindopril/amlodipine/indapamide to the free equivalent combination in patients with hypertension from an Italian national health system perspective. Expert review of pharmacoeconomics & outcomes research (2024)
Pierre Levy, Tobiasz Lemański, Anna Lefevbre, Catriona Crossan, Jean-Baptiste Brière, Luca Degli Esposti, Zeba M Khan
Cost-effectiveness analysis comparing single-pill combination of perindopril/amlodipine/indapamide to the free equivalent combination in patients with hypertension from an Italian national health system perspective. Expert review of pharmacoeconomics & outcomes research (2024)
Pierre Levy, Tobiasz Lemański, Catriona Crossan, Anna Lefebvre, Jean-Baptiste Brière, Luca Degli Esposti, Zeba M Khan
Cost-effectiveness analysis comparing single-pill combination of perindopril/amlodipine/indapamide to the free equivalent combination in patients with hypertension from an Italian national health system perspective. Expert review of pharmacoeconomics & outcomes research (2024)
Zeba M Khan, Jean-Baptiste Brière, Elzbieta Olewinska, Fatma Khrouf, Mateusz Nikodem
Ivabradine in patients with heart failure: a systematic literature review. Journal of market access & health policy 11 (1) (2023)